Katsuhisa Omagari1,2, Kazuhito Suruga1,2, Akira Kyogoku1, Satomi Nakamura1, Ai Sakamoto1, Shinta Nishioka2, Mayuko Ichimura2, Yuji Miyata3, Koichi Tajima4, Koichi Tsuneyama5, Kazunari Tanaka1,2. 1. Department of Nutrition, Faculty of Nursing and Nutrition, Graduate School of Human Health Science, University of Nagasaki, Nagasaki, Japan. 2. Division of Nutritional Science, Graduate School of Human Health Science, University of Nagasaki, Nagasaki, Japan. 3. Agriculture and Forestry Technical Development Center, Nagasaki Pref, Tea Laboratory, Nagasaki, Japan. 4. Agriculture and Forestry Technical Development Center, Nagasaki Pref, Forest Research Section, Nagasaki, Japan. 5. Department of Pathology and Laboratory Medicine, Tokushima University Graduate School, Tokushima, Japan.
Abstract
BACKGROUND: Established treatments for non-alcoholic steatohepatitis (NASH) are few, thus it is imperative to develop novel dietary strategies that can prevent NASH. A fermented mixed tea (FMT) made with Camellia japonica (Japanese camellia) and third- crop green tea leaves by tea-rolling processing was reported to reduce body weight and adipose tissue weight in Sprague-Dawley (SD) rats. Because visceral fat is one of the most important factors for the development of hepatic steatosis, this FMT supplementation can be a candidate dietary strategy for the prevention of NASH. METHODS: Nine-week-old male SD rats were fed a high-fat and high-cholesterol (HFC) diets with or without FMT (camellia and third-crop green tea leaves at ratios of 1:5, 1:2 and 1:1) for 9 weeks (n=6-7/group). Histopathology, serology and expressions of fibrogenetic, proinflammatory, oxidative stress and lipid metabolism-related genes in the liver were evaluated. RESULTS: Histologically, HFC diet with FMT at a ratio of 1:5 dramatically reduced NASH progression (14%) compared to the HFC diet without FMT (100%). FMT at a ratio of 1:5 reduced hepatic steatosis due to the activation of microsomal triglyceride transfer protein, and FMT at a ratio of 1:2 reduced mRNA levels of some proinflammatory, lipid metabolism-related, fibrogenic and oxidative stress marker genes. CONCLUSIONS: Our data suggest that FMT at a ratio of 1:5 or 1:2 likely possesses a preventive effect on NASH progression.
BACKGROUND: Established treatments for non-alcoholic steatohepatitis (NASH) are few, thus it is imperative to develop novel dietary strategies that can prevent NASH. A fermented mixed tea (FMT) made with Camellia japonica (Japanese camellia) and third- crop green tea leaves by tea-rolling processing was reported to reduce body weight and adipose tissue weight in Sprague-Dawley (SD) rats. Because visceral fat is one of the most important factors for the development of hepatic steatosis, this FMT supplementation can be a candidate dietary strategy for the prevention of NASH. METHODS: Nine-week-old male SD rats were fed a high-fat and high-cholesterol (HFC) diets with or without FMT (camellia and third-crop green tea leaves at ratios of 1:5, 1:2 and 1:1) for 9 weeks (n=6-7/group). Histopathology, serology and expressions of fibrogenetic, proinflammatory, oxidative stress and lipid metabolism-related genes in the liver were evaluated. RESULTS: Histologically, HFC diet with FMT at a ratio of 1:5 dramatically reduced NASH progression (14%) compared to the HFC diet without FMT (100%). FMT at a ratio of 1:5 reduced hepatic steatosis due to the activation of microsomal triglyceride transfer protein, and FMT at a ratio of 1:2 reduced mRNA levels of some proinflammatory, lipid metabolism-related, fibrogenic and oxidative stress marker genes. CONCLUSIONS: Our data suggest that FMT at a ratio of 1:5 or 1:2 likely possesses a preventive effect on NASH progression.
Entities:
Keywords:
Camellia leaves; fermented tea; green tea leaves; high-fat and high-cholesterol (HFC) diet; nonalcoholic steatohepatitis
Authors: Rolf Teschke; Li Zhang; Lena Melzer; Johannes Schulze; Axel Eickhoff Journal: Expert Opin Drug Metab Toxicol Date: 2014-10-15 Impact factor: 4.481
Authors: David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal Journal: Hepatology Date: 2005-06 Impact factor: 17.425
Authors: Stergios A Polyzos; Konstantinos N Aronis; Jannis Kountouras; Dimitrios D Raptis; Maria F Vasiloglou; Christos S Mantzoros Journal: Diabetologia Date: 2015-09-26 Impact factor: 10.122
Authors: Jinhui Li; Teryn N Sapper; Eunice Mah; Swetha Rudraiah; Kevin E Schill; Chureeporn Chitchumroonchokchai; Meredith V Moller; Joshua D McDonald; Philip R Rohrer; José E Manautou; Richard S Bruno Journal: Mol Nutr Food Res Date: 2016-02-18 Impact factor: 5.914